Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1/2 Trial Evaluating the Effectiveness and Safety of Dose-adapted HYpofractionated Pelvic Radiotherapy for Advanced Cervical Cancers INeligible for ChemoTherapy

NCT05210270 is registered in ClinicalTrials.gov with University of Santo Tomas Hospital, Philippines as lead sponsor.

NCT NCT05210270
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05210270 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1/2 Trial Evaluating the Effectiveness and Safety of Dose-adapted HYpofractionated Pelvic Radiotherapy for Advanced Cervical Cancers INeligible for ChemoTherapy
Lead sponsor
University of Santo Tomas Hospital, Philippines
Phase
Phase 1/2
Overall status
Not yet recruiting
Start date
January 31, 2024
Completion date
March 31, 2030
Enrollment
55 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

locally advanced cervical carcinoma